Hu et al. showed that arsenic trioxide exerted a potential therapeutic response by decreasing IL-10 and TGF-β levels in TILs from ascites of gastric cancer patients, with the proportion of CD4+CD25+CD127-Tregs decreasing and the CD8+ T cells frequency and IFN-γ level increasing [116]. Here, IL10 is linked to gastric cancer.